• Department of Pharmaceutical Teaching and Research, School of Bioengineering, Zunyi Medical University, Zhuhai 519041, China;
HE Xirui, Email: xiruihe610594@163.com
Export PDF Favorites Scan Get Citation

To analyze the adverse drug reactions (ADRs) induced by levetiracetam, providing a scientific basis and reference for clinical safe and rational drug use.Using Chinese search terms such as "levetiracetam", " antiepileptic", "adverse drug reaction", "side effect", and English search terms such as "levetiracetam", "antiepileptic", "adverse reaction", "ADR", "side effect", and "induced", we conducted a literature search in databases including CNKI, Wanfang Data, VIP Biomedical Database, PubMed, and Web of Science from the inception of the databases until March 1, 2025. Relevant information was extracted and statistically analyzed. A total of 39 articles were included, involving 46 patients, of which 24 were male (52.17%) and 22 were female (47.83%). ADRs involved 9 organ/systems, primarily the nervous system (39.13%), muscular system (32.61%), skin (13.04%), and urinary system (10.87%), including symptoms such as irritability, hallucinations, cognitive impairment, rhabdomyolysis, papules, and frequent urination. ADRs induced by levetiracetam affect multiple organ/systems. During clinical use, patient conditions should be regularly monitored, and the dosage should be promptly reduced or discontinued upon the occurrence of adverse reactions to mitigate clinical risks.

Citation: LIANG Suiling, LI Weitao, CHEN Jihuan, TIAN Ruoshi, YANG Yan, HE Xirui. Literature analysis of adverse reactions of levetiracetam in epilepsy treatment. Journal of Epilepsy, 2025, 11(3): 243-249. doi: 10.7507/2096-0247.202504001 Copy

Copyright © the editorial department of Journal of Epilepsy of West China Medical Publisher. All rights reserved

  • Previous Article

    Research progress of Lennox-Gastaut syndrome
  • Next Article

    Research progress on the diagnosis, treatment, and prognosis of status epilepticus